Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-11-28 17:12 | 2017-11-27 | N-A | N/A | STRS OHIO | 10% owner | Other | BUY | $15.00 | 155,404 | $2,331,067 | 14,940,514 | +1.1% |
| 2017-11-29 03:02 | 2017-11-24 | BH | N/A | BIGLARI, SARDAR | Director, 10% owner | Other | BUY | $334.10 | 3,053 | $1,019,994 | 663,194 | +0.5% |
| 2017-11-29 00:01 | 2017-11-24 | PSEC | PROSPECT CAPITAL CORP | Barry John F | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | Other | BUY | $6.82 | 279,666 | $1,907,742 | 26,708,671 | +1.1% |
| 2017-11-29 01:40 | 2017-11-27 | POPE | N/A | POPE MARIA M | Director | Other | BUY | $70.18 | 26,045 | $1,827,903 | 21,212 | +100.0% |
| 2017-11-27 20:46 | 2017-11-24 | JCI | Johnson Controls International plc | Oliver George | Officer - Chairman & CEO | Air-Cond & Warm Air Heatg Equip & Comm & Indl Refrig Equip | BUY | $36.80 | 27,300 | $1,004,626 | 634,732 | +4.5% |
| 2017-11-28 03:41 | 2017-11-16 | TRN | TRINITY INDUSTRIES INC | ValueAct Holdings, L.P. | 10% owner | Railroad Equipment | BUY | $33.00 | 55,000 | $1,815,000 | 18,607,352 | +0.3% |
| 2017-11-28 00:02 | 2017-11-22 | PSEC | PROSPECT CAPITAL CORP | Barry John F | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | Other | BUY | $6.72 | 162,826 | $1,094,126 | 26,425,625 | +0.6% |
| 2017-11-28 01:12 | 2017-11-27 | TEP | N/A | DEHAEMERS DAVID G JR | Director, Officer - President and CEO | Other | BUY | $42.50 | 31,501 | $1,338,793 | 540,817 | +6.2% |
| 2017-11-28 01:31 | 2017-11-22 | ETM | N/A | FIELD JOSEPH M | Director, Officer - Chairman Emeritus | Other | BUY | $11.81 | 168,162 | $1,985,657 | 3,877,621 | +4.5% |
| 2017-11-25 00:01 | 2017-11-21 | PSEC | PROSPECT CAPITAL CORP | Barry John F | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | Other | BUY | $6.90 | 1,043,386 | $7,194,773 | 26,262,799 | +4.1% |
| 2017-11-25 00:33 | 2017-11-21 | SCPH | N/A | SUN PHARMACEUTICAL INDUSTRIES LTD | 10% owner | Other | BUY | $14.00 | 357,143 | $5,000,002 | 357,143 | +100.0% |
| 2017-11-23 01:50 | 2017-11-20 | SD | SANDRIDGE ENERGY INC | ICAHN CARL C | 10% owner | Crude Petroleum & Natural Gas | BUY | $16.34 | 1,257,242 | $20,547,860 | 4,818,832 | +35.3% |
| 2017-11-23 00:06 | 2017-11-21 | N/A | N/A | Golub Lawrence E | Director, Officer - Chairman | Other | BUY | $15.00 | 67,354 | $1,010,303 | 1,394,955 | +5.1% |
| 2017-11-23 00:05 | 2017-11-21 | N/A | N/A | Golub David | Director, Officer - President and CEO | Other | BUY | $15.00 | 67,354 | $1,010,303 | 1,394,955 | +5.1% |
| 2017-11-23 00:01 | 2017-11-20 | PSEC | PROSPECT CAPITAL CORP | Barry John F | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | Other | BUY | $6.98 | 995,883 | $6,948,375 | 25,219,413 | +4.1% |
| 2017-11-22 16:30 | 2017-11-21 | DS | N/A | EDENS WESLEY R | Director | Other | BUY | $6.00 | 482,697 | $2,896,182 | 2,737,094 | +21.4% |
| 2017-11-23 01:56 | 2017-11-20 | JOE | ST JOE Co | FAIRHOLME CAPITAL MANAGEMENT LLC | Director, 10% owner | Land Subdividers & Developers (No Cemeteries) | BUY | $18.83 | 200,000 | $3,766,000 | 26,880,585 | +0.7% |
| 2017-11-23 00:22 | 2017-11-21 | GE | GENERAL ELECTRIC CO | TISCH JAMES S | Director | Electronic & Other Electrical Equipment (No Computer Equip) | BUY | $17.90 | 3,000,000 | $53,712,300 | 3,000,000 | +100.0% |
| 2017-11-22 00:24 | 2017-11-21 | N-A | N/A | STRS OHIO | 10% owner | Other | BUY | $15.00 | 400,000 | $6,000,000 | 14,785,109 | +2.8% |
| 2017-11-22 03:24 | 2017-11-21 | SCPH | N/A | Lundbeckfond Invest A/S | 10% owner | Other | BUY | $14.00 | 654,762 | $9,166,668 | 3,183,986 | +25.9% |
| 2017-11-21 20:01 | 2017-11-17 | CDXC | Niagen Bioscience, Inc. | Champion River Ventures Ltd | 10% owner | Medicinal Chemicals & Botanical Products | BUY | $4.10 | 731,707 | $2,999,999 | 6,500,937 | +12.7% |
| 2017-11-22 01:41 | 2017-11-20 | AAT | American Assets Trust, Inc. | RADY ERNEST S | Director, Officer, 10% owner - Chairman, CEO & President | Real Estate Investment Trusts | BUY | $39.34 | 40,167 | $1,580,266 | 1,249,332 | +3.3% |
| 2017-11-22 03:16 | 2017-11-21 | SCPH | N/A | 5AM Partners IV, LLC | 10% owner | Other | BUY | $14.00 | 654,762 | $9,166,668 | 130,135 | +100.0% |
| 2017-11-22 02:23 | 2017-11-20 | ETM | N/A | FIELD JOSEPH M | Director, Officer - Chairman Emeritus | Other | BUY | $11.72 | 180,282 | $2,112,959 | 3,709,459 | +5.1% |
| 2017-11-22 03:13 | 2017-11-21 | SCPH | N/A | ORBIMED ADVISORS LLC | 10% owner | Other | BUY | $14.00 | 833,333 | $11,666,662 | 3,409,865 | +32.3% |
| 2017-11-21 18:30 | 2017-11-17 | GEL | GENESIS ENERGY LP | Davison James E | Director | Pipe Lines (No Natural Gas) | BUY | $21.56 | 79,031 | $1,703,679 | 2,435,025 | +3.4% |
| 2017-11-21 02:15 | 2017-11-20 | ASNS | X4 Pharmaceuticals, Inc | NeoMed Innovation V L.P. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 300,000 | $3,000,000 | 867,639 | +52.9% |
| 2017-11-21 01:43 | 2017-11-20 | ASNS | X4 Pharmaceuticals, Inc | Nessi Claudio | Director | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 300,000 | $3,000,000 | 867,639 | +52.9% |
| 2017-11-21 01:32 | 2017-11-20 | ASNS | X4 Pharmaceuticals, Inc | Gerngross Tillman U. | Director | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 200,000 | $2,000,000 | 392,821 | +103.7% |
| 2017-11-21 00:55 | 2017-11-16 | MRTX | N/A | Boxer Capital, LLC | 10% owner | Other | BUY | $13.00 | 400,000 | $5,200,000 | 3,135,966 | +14.6% |
| 2017-11-21 01:37 | 2017-11-20 | ASNS | X4 Pharmaceuticals, Inc | SVLSF V, LLC | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 500,000 | $5,000,000 | 1,868,961 | +36.5% |
| 2017-11-21 02:00 | 2017-11-16 | VRX | Bausch Health Companies Inc. | Paulson John | Director | Pharmaceutical Preparations | BUY | $14.40 | 344,216 | $4,955,506 | 21,183,251 | +1.7% |
| 2017-11-21 01:07 | 2017-11-16 | APPN | Appian Corporation | Abdiel Capital Management, LLC | 10% owner | Services-Prepackaged Software | BUY | $20.15 | 450,000 | $9,066,510 | 4,293,770 | +11.7% |
| 2017-11-21 02:18 | 2017-11-16 | TRN | TRINITY INDUSTRIES INC | ValueAct Holdings, L.P. | 10% owner | Railroad Equipment | BUY | $33.00 | 42,970 | $1,418,010 | 18,595,322 | +0.2% |
| 2017-11-20 18:42 | 2017-11-16 | GPRE | Green Plains Inc. | Hoovestol Wayne | Director | Industrial Organic Chemicals | BUY | $16.37 | 102,653 | $1,680,553 | 276,030 | +59.2% |
| 2017-11-21 01:28 | 2017-11-20 | ASNS | X4 Pharmaceuticals, Inc | Polaris Venture Management Co. V, L.L.C. | 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 500,000 | $5,000,000 | 18,031 | +100.0% |
| 2017-11-21 01:31 | 2017-11-20 | ASNS | X4 Pharmaceuticals, Inc | GORDON CARL L | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 500,000 | $5,000,000 | 1,868,966 | +36.5% |
| 2017-11-21 00:03 | 2017-11-16 | USEL | N/A | PITON CAPITAL PARTNERS LLC | 10% owner | Other | BUY | $0.50 | 2,000,000 | $1,000,000 | 4,358,837 | +84.8% |
| 2017-11-21 04:01 | 2017-11-17 | PNR | PENTAIR plc | GARDEN EDWARD P | Director | Special Industry Machinery (No Metalworking Machinery) | BUY | $68.41 | 384,571 | $26,307,387 | 15,400,719 | +2.6% |
| 2017-11-21 01:28 | 2017-11-20 | ASNS | X4 Pharmaceuticals, Inc | Ross Michael Jay | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 500,000 | $5,000,000 | 1,868,961 | +36.5% |
| 2017-11-21 01:36 | 2017-11-20 | ASNS | X4 Pharmaceuticals, Inc | MCGUIRE TERRANCE | Director, 10% owner | Biological Products, (No Diagnostic Substances) | BUY | $10.00 | 500,000 | $5,000,000 | 18,031 | +100.0% |
| 2017-11-20 23:40 | 2017-11-20 | RE | EVEREST GROUP, LTD. | GALTNEY WILLIAM F JR | Director | Fire, Marine & Casualty Insurance | BUY | $225.29 | 6,000 | $1,351,730 | 40,750 | +17.3% |
| 2017-11-20 18:11 | 2017-11-16 | COTY | COTY INC. | JAB Cosmetics B.V. | 10% owner | Perfumes, Cosmetics & Other Toilet Preparations | BUY | $16.94 | 2,800,000 | $47,425,000 | 286,008,041 | +1.0% |
| 2017-11-17 16:17 | 2017-11-15 | GE | GENERAL ELECTRIC CO | Flannery John Leonard | Officer - Chairman and CEO | Electronic & Other Electrical Equipment (No Computer Equip) | BUY | $18.27 | 60,000 | $1,096,200 | 575,477 | +11.6% |
| 2017-11-18 01:50 | 2017-11-17 | SEND | N/A | Bessemer Venture Partners VIII L.P. | 10% owner | Other | BUY | $16.00 | 625,000 | $10,000,000 | 7,936,635 | +8.5% |
| 2017-11-18 00:15 | 2017-11-15 | DS | N/A | EDENS WESLEY R | Director | Other | BUY | $4.50 | 257,091 | $1,156,910 | 2,254,397 | +12.9% |
| 2017-11-18 00:22 | 2017-11-15 | ST | Sensata Technologies Holding plc | EDGERLEY PAUL B | Director | Industrial Instruments For Measurement, Display, and Control | BUY | $47.47 | 200,000 | $9,494,480 | 200,000 | +100.0% |
| 2017-11-18 03:13 | 2017-11-15 | JOE | ST JOE Co | FAIRHOLME CAPITAL MANAGEMENT LLC | Director, 10% owner | Land Subdividers & Developers (No Cemeteries) | BUY | $18.48 | 199,700 | $3,690,736 | 174,800 | +100.0% |
| 2017-11-18 04:09 | 2017-11-15 | LXRX | LEXICON PHARMACEUTICALS, INC. | Invus Public Equities, L.P. | Director, 10% owner | Pharmaceutical Preparations | BUY | $10.11 | 180,727 | $1,826,897 | 1,550,000 | +13.2% |
| 2017-11-17 01:15 | 2017-11-14 | MXWL | N/A | Buchheim Jorg | Director | Other | BUY | $5.18 | 250,000 | $1,295,000 | 328,180 | +319.8% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.